This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Beckman Coulter this week decided not to match a $92.50 per share bid by Inverness Medical Innovations to buy Biosite, effectively ending its plans to acquire the diagnostics firm.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.